Simplex Trading
ALXN

Simplex Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Simplex Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,712
Closed -$3.44M – 10025
2021
Q2 		$3.44M Sell
18,712
-16,844
-47% -$2.89M ﹤0.01% 1535
2021
Q1 		$5.44M Sell
35,556
-46,581
-57% -$7.21M 0.01% 766
2020
Q4 		$12.8M Buy
82,137
+36,147
+79% +$4.64M 0.02% 484
2020
Q3 		$0 Sell
45,990
-3,459
-7% -$373K ﹤0.01% 8865
2020
Q2 		$5.55M Sell
49,449
-21,356
-30% -$2.27M 0.01% 797
2020
Q1 		$6.36M Buy
70,805
+45,926
+185% +$4.51M 0.01% 579
2019
Q4 		$2.69M Sell
24,879
-31,018
-55% -$3.32M 0.01% 1236
2019
Q3 		$5.47M Buy
55,897
+13,488
+32% +$1.52M 0.02% 668
2019
Q2 		$5.55M Buy
+42,409
New +$5.47M 0.02% 629
2019
Q1 		– Sell
-5,423
Closed -$674K – 8189
2018
Q4 		$527K Sell
5,423
-12,713
-70% -$1.5M ﹤0.01% 2182
2018
Q3 		$2.52M Sell
18,136
-6,051
-25% -$759K 0.01% 1054
2018
Q2 		$3M Sell
24,187
-25,804
-52% -$3.02M 0.01% 858
2018
Q1 		$5.57M Buy
49,991
+49,838
+32,574% +$5.96M 0.24% 76
2017
Q4 		$18K Buy
+153
New +$18.6K ﹤0.01% 3413
2017
Q3 		– Sell
-6,937
Closed -$942K – 6944
2017
Q2 		$844K Sell
6,937
-10,991
-61% -$1.28M 0.04% 429
2017
Q1 		$2.17M Buy
17,928
+9,629
+116% +$1.24M 0.09% 191
2016
Q4 		$1.01M Sell
8,299
-8,720
-51% -$1.07M 0.06% 278
2016
Q3 		$2.08M Buy
17,019
+922
+6% +$119K 0.14% 129
2016
Q2 		$1.88M Buy
+16,097
New +$2.28M 0.13% 152
2015
Q4 		– Sell
-3,351
Closed -$585K – 6421
2015
Q3 		$524K Buy
3,351
+349
+12% +$63.7K 0.04% 430
2015
Q2 		$542K Buy
3,002
+133
+5% +$23K 0.05% 373
2015
Q1 		$497K Buy
2,869
+1,821
+174% +$330K 0.06% 333
2014
Q4 		$194K Buy
+1,048
New +$194K 0.02% 618

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Simplex Trading's ALXN Position: Q3 2021 in Review

Simplex Trading sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 18,712 shares — an estimated $3.44M sold.

Simplex Trading first reported a position in ALXN in Q4 2014 and held it in 23 quarters. The position peaked at $12.8M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Simplex Trading reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Simplex Trading sold 18,712 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.44M.
  • Simplex Trading first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 23 quarters.
  • Simplex Trading's Alexion Pharmaceuticals position peaked at $12.8M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Simplex Trading's 13F filing for Q3 2021, filed 28 Oct 2021.